Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment.

MLA

Anmella, Gerard, et al. “Exploring Clinical Subgroups of Participants with Major Depressive Disorder That May Benefit from Adjunctive Minocycline Treatment.” Clinical Psychopharmacology & Neuroscience, vol. 22, no. 1, Jan. 2024, pp. 33–44. EBSCOhost, https://doi.org/10.9758/cpn.23.1098.

APA

Anmella, G., Meehan, A., Ashton, M., Mohebbi, M., Fico, G., Ng, C. H., Maes, M., Berk, L., De Prisco, M., Singh, A. B., Malhi, G. S., Berk, M., Dodd, S., Hidalgo-Mazzei, D., Grande, I., Pacchiarotti, I., Murru, A., Vieta, E., & Dean, O. M. (2024). Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment. Clinical Psychopharmacology & Neuroscience, 22(1), 33–44. https://doi.org/10.9758/cpn.23.1098

Chicago

Anmella, Gerard, Alcy Meehan, Melanie Ashton, Mohammadreza Mohebbi, Giovanna Fico, Chee H. Ng, Michael Maes, et al. 2024. “Exploring Clinical Subgroups of Participants with Major Depressive Disorder That May Benefit from Adjunctive Minocycline Treatment.” Clinical Psychopharmacology & Neuroscience 22 (1): 33–44. doi:10.9758/cpn.23.1098.